{"title":"Occurrence of Comorbid Metabolic and Depressive Symptoms across Sociodemographic Categories in the United States.","authors":"Tyra Dark, George Rust","doi":"10.18865/EthnDis-2024-29","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study was conducted to quantify the prevalence of metabolic syndrome and depressive symptoms across racial/ethnic and socioeconomic strata in a nationally representative U.S. sample.</p><p><strong>Methods: </strong>We used National Health and Nutrition Examination Survey 2017-March 2020 data for participants aged 18 years and older. Prevalence of depressive symptoms and metabolic syndrome alone and in combination was measured across racial/ethnic, sex, age, and income strata. Chi-square tests were used for between-group comparisons.</p><p><strong>Results: </strong>Over 7% of sampled adults had comorbid depressive symptoms and metabolic syndrome, representing 18.3 million Americans. These conditions were not equally distributed across racial/ethnic groups (χ<sup>2</sup>=124.28, P<.0001). The non-Hispanic Asian group was least likely to have either condition. Differences by economic status were also significant (χ<sup>2</sup>=86.61, P<.0001). Those in the highest economic group were least likely to have either or both conditions.</p><p><strong>Conclusions: </strong>Disparities in comorbid conditions exist across socioeconomic and demographic strata. Achieving optimal and equitable health outcomes for people with these comorbidities will require \"whole-person-in-context\" interventions. Integrated approaches to coexisting medical, psychological, and social complexities are needed.</p>","PeriodicalId":50495,"journal":{"name":"Ethnicity & Disease","volume":"35 2","pages":"83-86"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080750/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethnicity & Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18865/EthnDis-2024-29","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study was conducted to quantify the prevalence of metabolic syndrome and depressive symptoms across racial/ethnic and socioeconomic strata in a nationally representative U.S. sample.
Methods: We used National Health and Nutrition Examination Survey 2017-March 2020 data for participants aged 18 years and older. Prevalence of depressive symptoms and metabolic syndrome alone and in combination was measured across racial/ethnic, sex, age, and income strata. Chi-square tests were used for between-group comparisons.
Results: Over 7% of sampled adults had comorbid depressive symptoms and metabolic syndrome, representing 18.3 million Americans. These conditions were not equally distributed across racial/ethnic groups (χ2=124.28, P<.0001). The non-Hispanic Asian group was least likely to have either condition. Differences by economic status were also significant (χ2=86.61, P<.0001). Those in the highest economic group were least likely to have either or both conditions.
Conclusions: Disparities in comorbid conditions exist across socioeconomic and demographic strata. Achieving optimal and equitable health outcomes for people with these comorbidities will require "whole-person-in-context" interventions. Integrated approaches to coexisting medical, psychological, and social complexities are needed.
期刊介绍:
Ethnicity & Disease is an international journal that exclusively publishes information on the causal and associative relationships in the etiology of common illnesses through the study of ethnic patterns of disease. Topics focus on: ethnic differentials in disease rates;impact of migration on health status; social and ethnic factors related to health care access and health; and metabolic epidemiology. A major priority of the journal is to provide a forum for exchange between the United States and the developing countries of Europe, Africa, Asia, and Latin America.